Search - tctmd.com

Displaying 321 - 340 of 2747

Sort: Relevancy | Date

Presentation TCT 2024

TCT 1583: Successful Multidisciplinary Management of Late Presentation of HOCM With Severe Pumonary Hypertension With Multiple Interventional Techniques

Presenter: Sukhdeep Basra

October 30, 2024

Presentation TCT 2024

TCT 817: Impact of Pulmonary Hypertension on Outcomes of PCI in Acute Myocardial Infarction: A Contemporary 5-Year Nationwide Analysis

Presenter: Viet Nghi Tran

October 29, 2024

Presentation TCT 2024

Debate Pro: RDN Could Be Useful for the Majority of Patients with Uncontrolled HTN

Presenter: Raymond Townsend

October 29, 2024

Presentation TCT 2024

Debate Con: RDN Will Ultimately Be a Niche Therapy

Presenter: Andrew Sharp

October 29, 2024

Presentation TCT 2024

Debate Con: Predictors of Efficacy are Sorely Needed in the RDN Space!

Presenter: Eric Secemsky

October 29, 2024

Presentation TCT 2024

Debate Pro: Predictors of Efficacy are Not Needed for Most Patients

Presenter: Michael Weber

October 29, 2024

Presentation TCT 2024

How to Set Up Your RDN Hypertension Program: Team Members and Patient Flow

Presenter: Michael Bloch

October 29, 2024

Presentation TCT 2024

What Evaluation is Required for Patient Selection for RDN?

Presenter: Naomi Fisher

October 29, 2024

Presentation TCT 2024

Case 2: TTVI in Pulmonary Hypertension – Where Do We Draw the Line for Interventional Treatment?

Presenter: Laura Davidson

October 29, 2024

Presentation TCT 2024

TCT 621: Up to 20 Years Follow-Up of Severe Pulmonary Artery Hypertension Percutaneous Mitral Balloon Commissurotomy Due to Rheumatic Mitral Valve Disease

Presenter: Rafael Meneguz-Moreno

October 28, 2024

Presentation TCT 2024

Multiorgan Denervation in Hypertension and Beyond – From Renal to Hepatic

Presenter: Raven Voora

October 28, 2024

Presentation TCT 2024

Alternative Renal Denervation Devices – From Ablative Solutions to Verve

Presenter: Michael Weber

October 28, 2024

Presentation TCT 2024

Ultrasound Renal Denervation in Hypertension – From Paradise to Sonivie

Presenter: Naomi Fisher

October 28, 2024

Presentation TCT 2024

Radiofrequency Renal Denervation in Hypertension – From Symplicity to Iberis HTN

Presenter: Lucas Lauder

October 28, 2024

Presentation TCT 2024

TCT 728: Catheter-Directed Intervention for High-Risk Acute Pulmonary Embolism in Chronic Kidney Disease

Presenter: Manoj Kumar

October 28, 2024

Presentation TCT 2024

TCT 729: Thirty-Day Outcome of Pharmacomechanical Devices in Treating Intermediate Risk Pulmonary Embolization: Real World Data From Two Medical Centers

Presenter: William Sharis

October 28, 2024

Presentation TCT 2024

TCT 727: The Role of Pulmonary Artery Pulsatility Index to Assess the Outcomes Following Catheter Directed Therapy in Patients With Intermediate-to-High and High-Risk Pulmonary Embolism

Presenter: Marco Gamardella

October 28, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

Presentation TCT 2024

Final Results of the Novel Healing-Targeted DES With Synchronized Antiproliferative Drug Delivery to Target Smooth Muscle Cell Proliferation After DES Implantation in Coronary Artery Disease: 5-Year Results of the PIONEER III Trial

Presenter: Thomas Sharp

October 28, 2024

Presentation TCT 2024

TCT 485: Device-Related Adverse Events and Modes of Failure Related to Renal Denervation Systems: Insights From Analysis of the FDA MAUDE Database

Presenter: Manasa Jasti

October 28, 2024

Advertisement

TCT 1583: Successful Multidisciplinary Management of Late Presentation of HOCM With Severe Pumonary Hypertension With Multiple Interventional Techniques

TCT 817: Impact of Pulmonary Hypertension on Outcomes of PCI in Acute Myocardial Infarction: A Contemporary 5-Year Nationwide Analysis

Debate Pro: RDN Could Be Useful for the Majority of Patients with Uncontrolled HTN

Debate Con: RDN Will Ultimately Be a Niche Therapy

Debate Con: Predictors of Efficacy are Sorely Needed in the RDN Space!

Debate Pro: Predictors of Efficacy are Not Needed for Most Patients

How to Set Up Your RDN Hypertension Program: Team Members and Patient Flow

What Evaluation is Required for Patient Selection for RDN?

Case 2: TTVI in Pulmonary Hypertension – Where Do We Draw the Line for Interventional Treatment?

TCT 621: Up to 20 Years Follow-Up of Severe Pulmonary Artery Hypertension Percutaneous Mitral Balloon Commissurotomy Due to Rheumatic Mitral Valve Disease

Multiorgan Denervation in Hypertension and Beyond – From Renal to Hepatic

Alternative Renal Denervation Devices – From Ablative Solutions to Verve

Ultrasound Renal Denervation in Hypertension – From Paradise to Sonivie

Radiofrequency Renal Denervation in Hypertension – From Symplicity to Iberis HTN

TCT 728: Catheter-Directed Intervention for High-Risk Acute Pulmonary Embolism in Chronic Kidney Disease

TCT 729: Thirty-Day Outcome of Pharmacomechanical Devices in Treating Intermediate Risk Pulmonary Embolization: Real World Data From Two Medical Centers

TCT 727: The Role of Pulmonary Artery Pulsatility Index to Assess the Outcomes Following Catheter Directed Therapy in Patients With Intermediate-to-High and High-Risk Pulmonary Embolism

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

Final Results of the Novel Healing-Targeted DES With Synchronized Antiproliferative Drug Delivery to Target Smooth Muscle Cell Proliferation After DES Implantation in Coronary Artery Disease: 5-Year Results of the PIONEER III Trial

TCT 485: Device-Related Adverse Events and Modes of Failure Related to Renal Denervation Systems: Insights From Analysis of the FDA MAUDE Database

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content